Severe sepsis and septic shock: a prospective population-based study in Icelandic intensive care units

被引:18
|
作者
Vesteinsdottir, E. [1 ,2 ]
Karason, S. [1 ,2 ]
Sigurdsson, S. E. [3 ]
Gottfredsson, M. [2 ,4 ]
Sigurdsson, G. H. [1 ,2 ]
机构
[1] Landspitali Univ Hosp, Dept Anaesthesia & Intens Care, IS-101 Reykjavik, Iceland
[2] Univ Iceland, Fac Med, Reykjavik, Iceland
[3] Akureyri Hosp, Dept Anaesthesia & Intens Care, Akureyri, Iceland
[4] Landspitali Univ Hosp, Dept Infect Dis, IS-101 Reykjavik, Iceland
关键词
GOAL-DIRECTED THERAPY; ANTIMICROBIAL THERAPY; METHICILLIN-RESISTANT; ORGAN FAILURE; EPIDEMIOLOGY; MORTALITY; SURVIVAL; IMPACT; CANDIDAEMIA; CANDIDEMIA;
D O I
10.1111/j.1399-6576.2011.02437.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: The aims of our study were to describe the nationwide epidemiology of sepsis requiring intensive care during an entire year and to evaluate compliance with treatment guidelines. Methods: This was a prospective, observational study of all adult patients admitted to Icelandic intensive care units (ICUs), who were screened for the ACCP/SCCM criteria for severe sepsis or septic shock on admission. Data were collected from 1 April 2008 to 31 March 2009. Results: One thousand five hundred and twenty-four patients were admitted to the ICUs during the study year, 115 of them because of severe sepsis or septic shock. The incidence in Iceland was 0.48/1000 inhabitants >= 18 years per year [95% confidence intervals (CI) 0.42-0.55]. The mean APACHE II score was 20.7. Mortality was 24.6% (95% CI 17.5-33.3) at 28 days and 40.4% (95% CI 31.8-49.5) at 1 year. The main sources of infections were pulmonary (37%), abdominal (28%) and urinary tract (8%). Pathogens were gram-positive (39%), gram-negative (30%) and mixed (28%). No patient had sepsis caused by methicillin-resistant Staphylococcus aureus or a monomicrobial fungal infection. Pulmonary infections were an independent predictor of death. Compliance to the resuscitation goals of the Surviving Sepsis Campaign ranged from 60% to 72% and the 6-hour Sepsis Bundle was completed in 35% of patients. Conclusions: This nationwide study showed an incidence of 0.48/1000 inhabitants for severe sepsis and septic shock requiring intensive care therapy. The 28-day mortality rate of 25 % was in the lower range of previous reports but the compliance to resuscitation goals and sepsis bundles was similar.
引用
收藏
页码:722 / 731
页数:10
相关论文
共 50 条
  • [31] METABONOMIC STUDY ON PATIENTS DIAGNOSED WITH SEVERE SEPSIS AND SEPTIC SHOCK IN THE INTENSIVE UNIT
    Garcia Simon, M.
    Morales Tatay, J. M.
    Monleon Salvado, D.
    Modesto i Alapont, V.
    Vento Rehues, R.
    Jorda Minana, A.
    Blanquer Olivas, J.
    [J]. INTENSIVE CARE MEDICINE, 2012, 38 : S98 - S99
  • [32] Long-term mortality after severe sepsis and septic shock in Swedish intensive care units 2005-2015
    Strandberg, Gunnar
    Walther, Sten
    Ohman, Christina Agvald
    Lipcsey, Miklos
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2017, 61 (08) : 1039 - 1039
  • [33] Classification of the Gut Microbiota of Patients in Intensive Care Units During Development of Sepsis and Septic Shock
    Wanglin Liu
    Mingyue Cheng
    Jinman Li
    Peng Zhang
    Hang Fan
    Qinghe Hu
    Maozhen Han
    Longxiang Su
    Huaiwu He
    Yigang Tong
    Kang Ning
    Yun Long
    [J]. Genomics,Proteomics & Bioinformatics, 2020, (06) - 707
  • [34] Classification of the Gut Microbiota of Patients in Intensive Care Units During Development of Sepsis and Septic Shock
    Liu, Wanglin
    Cheng, Mingyue
    Li, Jinman
    Zhang, Peng
    Fan, Hang
    Hu, Qinghe
    Han, Maozhen
    Su, Longxiang
    He, Huaiwu
    Tong, Yigang
    Ning, Kang
    Long, Yun
    [J]. GENOMICS PROTEOMICS & BIOINFORMATICS, 2020, 18 (06) : 696 - 707
  • [35] Classification of the Gut Microbiota of Patients in Intensive Care Units During Development of Sepsis and Septic Shock
    Wanglin Liu
    Mingyue Cheng
    Jinman Li
    Peng Zhang
    Hang Fan
    Qinghe Hu
    Maozhen Han
    Longxiang Su
    Huaiwu He
    Yigang Tong
    Kang Ning
    Yun Long
    [J]. Genomics,Proteomics & Bioinformatics, 2020, 18 (06) : 696 - 707
  • [36] HOSPITAL OUTCOMES AND COSTS OF CARE FOR SEVERE SEPSIS: A POPULATION-BASED STUDY
    Bouza, C.
    Lopez-Cuadrado, T.
    Saz-Parkinson, Z.
    Amate, J. M.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A247 - A247
  • [37] Intensive insulin therapy in patients with severe sepsis and septic shock
    Villamarin, Ricardo I.
    Puentes, Fabian E.
    [J]. ARCHIVOS DE MEDICINA, 2009, 9 (02): : 165 - 173
  • [38] Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem during the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units
    Jaruratanasirikul, Sutep
    Thengyai, Suriyan
    Wongpoowarak, Wibul
    Wattanavijitkul, Thitima
    Tangkitwanitjaroen, Kanyawisa
    Sukarnjanaset, Waroonrat
    Jullangkoon, Monchana
    Samaeng, Maseetoh
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (06) : 2995 - 3001
  • [39] Biomarkers of severe sepsis and septic shock in patients admitted to a Danish multi disciplinary Intensive Care Unit (ICU) - a prospective, observational pilot study
    Krog, J.
    Bundgaard, H.
    Jorgensen, H. S.
    Tonnesen, E.
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2009, 53 : 72 - 72
  • [40] TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study
    A C Gordon
    A L Lagan
    E Aganna
    L Cheung
    C J Peters
    M F McDermott
    J L Millo
    K I Welsh
    P Holloway
    G A Hitman
    R D Piper
    C S Garrard
    C J Hinds
    [J]. Genes & Immunity, 2004, 5 : 631 - 640